94 related articles for article (PubMed ID: 22118544)
41. A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity.
Maeyama J; Takatsuka H; Suzuki F; Kubota A; Horiguchi S; Komiya T; Shimada I; Murata E; Osawa Y; Kitagawa H; Matsuki T; Isaka M; Yamamoto S; Iho S
PLoS One; 2014; 9(2):e88846. PubMed ID: 24586411
[TBL] [Abstract][Full Text] [Related]
42. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.
Kovacs-Nolan J; Latimer L; Landi A; Jenssen H; Hancock RE; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2009 Mar; 27(14):2055-64. PubMed ID: 19428830
[TBL] [Abstract][Full Text] [Related]
43. Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
Andrews CD; Provoda CJ; Ott G; Lee KD
Bioconjug Chem; 2011 Jul; 22(7):1279-86. PubMed ID: 21612239
[TBL] [Abstract][Full Text] [Related]
44. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
[TBL] [Abstract][Full Text] [Related]
45. Immunological responses after immunisation of mice with microparticles containing antigen and single stranded RNA (polyuridylic acid).
Westwood A; Elvin SJ; Healey GD; Williamson ED; Eyles JE
Vaccine; 2006 Mar; 24(11):1736-43. PubMed ID: 16278038
[TBL] [Abstract][Full Text] [Related]
46. Mannosylated cationic liposomes/CpG DNA complex for the treatment of hepatic metastasis after intravenous administration in mice.
Kuramoto Y; Kawakami S; Zhou S; Fukuda K; Yamashita F; Hashida M
J Pharm Sci; 2009 Mar; 98(3):1193-7. PubMed ID: 18623219
[TBL] [Abstract][Full Text] [Related]
47. pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2017 Oct; 141():272-283. PubMed ID: 28704679
[TBL] [Abstract][Full Text] [Related]
48. CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV.
Zhao H; Han Q; Yang A; Wang Y; Wang G; Lin A; Wang X; Yin C; Zhang J
Int J Biol Sci; 2022; 18(1):154-165. PubMed ID: 34975324
[TBL] [Abstract][Full Text] [Related]
49. Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model.
Kwon S; Kim D; Park BK; Wu G; Park MC; Ha YW; Kwon HJ; Lee Y
Oncol Rep; 2013 Feb; 29(2):735-40. PubMed ID: 23138455
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of immunomodulatory activity by liposome-encapsulated natural phosphodiester bond CpG-DNA in a human B cell line.
Kim D; Rhee JW; Kwon S; Kim YE; Choi SY; Park J; Lee Y; Kwon HJ
BMB Rep; 2010 Apr; 43(4):250-6. PubMed ID: 20423609
[TBL] [Abstract][Full Text] [Related]
51. Liposome-encapsulated CpG enhances antitumor activity accompanying the changing of lymphocyte populations in tumor via intratumoral administration.
Kim DH; Moon C; Oh SS; Park S; Jeong JW; Kim S; Lee HG; Kwon HJ; Kim KD
Nucleic Acid Ther; 2015 Apr; 25(2):95-102. PubMed ID: 25692533
[TBL] [Abstract][Full Text] [Related]
52. Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers.
Kwon S; Kim D; Park BK; Cho S; Kim KD; Kim YE; Park CS; Ahn HJ; Seo JN; Choi KC; Kim DS; Lee Y; Kwon HJ
PLoS One; 2012; 7(3):e33121. PubMed ID: 22427965
[TBL] [Abstract][Full Text] [Related]
53. The role of CpG motifs in innate immunity.
Krieg AM
Curr Opin Immunol; 2000 Feb; 12(1):35-43. PubMed ID: 10679406
[TBL] [Abstract][Full Text] [Related]
54. CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice.
Pihlgren M; Tougne C; Schallert N; Bozzotti P; Lambert PH; Siegrist CA
Vaccine; 2003 Jun; 21(19-20):2492-9. PubMed ID: 12744883
[TBL] [Abstract][Full Text] [Related]
55. Stimulatory effect of CpG sequences on humoral response in chickens.
Vleugels B; Ververken C; Goddeeris BM
Poult Sci; 2002 Sep; 81(9):1317-21. PubMed ID: 12269610
[TBL] [Abstract][Full Text] [Related]
56. Immunostimulatory DNA sequences help to eradicate intracellular pathogens.
Wagner H; Häcker H; Lipford GB
Springer Semin Immunopathol; 2000; 22(1-2):147-52. PubMed ID: 10944809
[No Abstract] [Full Text] [Related]
57. Adjuvanticity of an ornithine-containing lipid of Flavobacterium meningosepticum as a candidate vaccine adjuvant.
Kato H; Goto N
Microbiol Immunol; 1997; 41(2):101-6. PubMed ID: 9087952
[TBL] [Abstract][Full Text] [Related]
58. CpG DNA: a novel immunomodulator.
Krieg AM
Trends Microbiol; 1999 Feb; 7(2):64-5. PubMed ID: 10081082
[No Abstract] [Full Text] [Related]
59. Enhanced adjuvantic property of polymerized liposome as compared to a phospholipid liposome.
Jeong JM; Chung YC; Hwang JH
J Biotechnol; 2002 Apr; 94(3):255-63. PubMed ID: 11861084
[TBL] [Abstract][Full Text] [Related]
60. Enhanced immunostimulatory effects of DNA-encapsulated peptide hydrogels.
Medina SH; Li S; Howard OM; Dunlap M; Trivett A; Schneider JP; Oppenheim JJ
Biomaterials; 2015; 53():545-53. PubMed ID: 25890750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
